# Yigefeng

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yigefeng

- Industry: Biotechnology
- Headquarters: Jilin, China
- Website: www.yigeshengwu.com
- Latest round: Series A (Jul 9, 2024)
- Investors on record: 1

## About

Founded in 2010 and based in Jilin, China, Yigefeng is a biotech company that focuses on the research and development of veterinary drugs. In August 2014, the company passed the veterinary drug GMP acceptance. In July 2024, the firm closed a series A funding. The company has a live vaccine workshop, an independent spleen and lymph vaccine workshop and a quality inspection room.

The company's main products include swine disease vaccines, chicken disease vaccines and duck disease vaccines. Swine disease vaccines include live vaccine for classical swine fever, live vaccine for porcine Pasteurella multocida and live vaccine for piglet paratyphoid.

The company’s revenue is generated by providing animal vaccines.

## Funding rounds

- Series A, Jul 9, 2024 — Jilin Province Technology Investment

## Investors

- Jilin Province Technology Investment (https://capitalatlas.ai/funds/jilin-province-technology-investment) — Series A